SEC Form 4 · accession 0001615774-16-004858
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andy Sassine
Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 9:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 5, 2016 | A | 250,000 | $0.00 | A | 4,298,221 | D |
Table II — derivative securities
No Table II lines on this filing.